Difference between revisions of "Part:BBa K3843005"

 
Line 1: Line 1:
  
 +
__NOTOC__
 +
<partinfo>BBa_K3843005 short</partinfo>
 +
 +
Streptavidin is a highly useful protein in molecular biology due to its high-affinity non-covalent interaction with biotin, a small molecule. This makes the biotin-streptavidin duo valuable as an affinity tag system. However, overexpression of streptavidin can be complicated by its tetrameric nature, making it harder to obtain large amounts for use in diagnostic assays. In a similar sense, the tetrameric nature of streptavidin makes it a bulky and non-optimal protein for use in a translational fusion protein. This is because bulkier fusion proteins tend to exhibit a higher risk of aggregation and instability, which is accentuated by the presence of multiple subunits. To mitigate these complications of working with streptavidin, __________ engineered a monomeric streptavidin using rational protein design. This engineered monomeric streptavidin (henceforth referred to as mSA2) eliminates the complications mentioned above, but displays a markedly lower affinity for biotin than its tetrameric counterpart (CITE). In hoping to further improve mSA2’s binding affinity to biotin for use in a diagnostic microfluidic assay, Waterloo iGEM (2021) used a computational workflow to perform rational protein design on mSA2. Each amino acid of mSA2 was iteratively mutated to determine the mutations yielding the lowest computational energy scores for the biotin-streptavidin complex, corresponding to improved binding.
 +
 +
<!-- Add more about the biology of this part here
 +
===Usage and Biology===
 +
 +
<!-- -->
 +
<span class='h3bb'>Sequence and Features</span>
 +
<partinfo>BBa_K3843005 SequenceAndFeatures</partinfo>
 +
 +
 +
<!-- Uncomment this to enable Functional Parameter display
 +
===Functional Parameters===
 +
<partinfo>BBa_K3843005 parameters</partinfo>
 +
<!-- -->

Revision as of 06:39, 1 October 2021


Affinity-improved monomeric streptavidin (mSA2+)

Streptavidin is a highly useful protein in molecular biology due to its high-affinity non-covalent interaction with biotin, a small molecule. This makes the biotin-streptavidin duo valuable as an affinity tag system. However, overexpression of streptavidin can be complicated by its tetrameric nature, making it harder to obtain large amounts for use in diagnostic assays. In a similar sense, the tetrameric nature of streptavidin makes it a bulky and non-optimal protein for use in a translational fusion protein. This is because bulkier fusion proteins tend to exhibit a higher risk of aggregation and instability, which is accentuated by the presence of multiple subunits. To mitigate these complications of working with streptavidin, __________ engineered a monomeric streptavidin using rational protein design. This engineered monomeric streptavidin (henceforth referred to as mSA2) eliminates the complications mentioned above, but displays a markedly lower affinity for biotin than its tetrameric counterpart (CITE). In hoping to further improve mSA2’s binding affinity to biotin for use in a diagnostic microfluidic assay, Waterloo iGEM (2021) used a computational workflow to perform rational protein design on mSA2. Each amino acid of mSA2 was iteratively mutated to determine the mutations yielding the lowest computational energy scores for the biotin-streptavidin complex, corresponding to improved binding.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]